India approves Corbevax, Covovax and Molnupiravir for emergency use

Union Health Minister Mansukh Mandaviya tweeted that Corbevax is the country's first indigenously developed RBD protein sub-unit Covid-19 vaccine.

India approves Corbevax, Covovax and Molnupiravir for emergency use

The Ministry of Health and Family Welfare has approved two new vaccines, Corbevax and Covavax and an anti viral drug Molnupiravir for use on adults in case of emergencies on Tuesday.

Union Health Minister Mansukh Mandaviya tweeted that Corbevax is the country's first indigenously developed RBD protein sub-unit COVID-19 vaccine made by drug company Biological-E. Covovax is produced by the Serum Institute of India.